Boothroyd Lucy J, Lambert Laurie J, Segal Eli, Ross Dave, Kouz Simon, Maire Sébastien, Harvey Richard, Xiao Yongling, Brown Kevin A, Nasmith James, Bogaty Peter
Cardiology Evaluation Unit, Institut national d'excellence en santé et en services sociaux, Montreal, Quebec, Canada.
Cardiology Evaluation Unit, Institut national d'excellence en santé et en services sociaux, Montreal, Quebec, Canada.
Am J Cardiol. 2014 Nov 1;114(9):1289-94. doi: 10.1016/j.amjcard.2014.07.060. Epub 2014 Aug 12.
In a systematic province-wide evaluation of care and outcomes of ST elevation myocardial infarction (STEMI), we sought to examine whether a previously documented association between ambulance use and outcome remains after control for clinical risk factors. All 82 acute care hospitals in Quebec (Canada) that treated at least 30 acute myocardial infarctions annually participated in a 6-month evaluation in 2008 to 2009. Medical record librarians abstracted hospital chart data for consecutive patients with a discharge diagnosis of myocardial infarction who presented with characteristic symptoms and met a priori study criteria for STEMI. Linkage to administrative databases provided outcome data (to 1 year) and co-morbidities. Of 1,956 patients, 1,222 (62.5%) arrived by ambulance. Compared with nonusers of an ambulance, users were older, more often women, and more likely to have co-morbidities, low systolic pressure, abnormal heart rate, and a higher Thrombolysis In Myocardial Infarction risk index at presentation. Ambulance users were less likely to receive fibrinolysis or to be sent for primary angioplasty (78.5% vs 83.2% for nonusers, p = 0.01), although if they did, treatment delays were shorter (p <0.001). The 1-year mortality rate was 18.7% versus 7.1% for nonusers (p <0.001). Greater mortality persisted after adjusting for presenting risk factors, co-morbidities, reperfusion treatment, and symptom duration (hazard ratio 1.56, 95% confidence interval 1.30 to 1.87). In conclusion, ambulance users with STEMI were older and sicker than nonusers. Mortality of users was substantially greater after adjustment for clinical risk factors, although they received faster reperfusion treatment overall.
在一项对全省ST段抬高型心肌梗死(STEMI)治疗及预后的系统性评估中,我们试图探究在控制临床风险因素后,先前记录的救护车使用与预后之间的关联是否依然存在。加拿大魁北克省所有每年至少治疗30例急性心肌梗死患者的82家急症医院参与了2008年至2009年为期6个月的评估。病历管理员提取了连续的出院诊断为心肌梗死且有典型症状并符合STEMI预先设定研究标准的患者的医院病历数据。与行政数据库的关联提供了预后数据(至1年)和合并症信息。在1956例患者中,1222例(62.5%)乘坐救护车抵达。与未使用救护车的患者相比,使用救护车的患者年龄更大,女性更多,更有可能患有合并症、收缩压低、心率异常,且就诊时心肌梗死溶栓风险指数更高。使用救护车的患者接受纤维蛋白溶解治疗或被送去进行直接血管成形术的可能性较小(使用救护车者为78.5%,未使用者为83.2%,p = 0.01),不过如果他们接受了这些治疗,治疗延迟时间更短(p <0.001)。使用救护车者的1年死亡率为18.7%,未使用者为7.1%(p <0.001)。在对就诊时的风险因素、合并症、再灌注治疗和症状持续时间进行调整后,较高的死亡率依然存在(风险比1.56,95%置信区间1.30至1.87)。总之,STEMI使用救护车的患者比未使用者年龄更大且病情更重。尽管总体上他们接受了更快的再灌注治疗,但在对临床风险因素进行调整后,使用者的死亡率仍显著更高。